Spreadsheet: 51f6793f-71e1-445c-8c35-0037092647ce
Sheet: Sheet1

si RNA treatment, up regulated genes | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4
Category | Function Annotation | P-value | Molecules | # Molecules
Reproductive System Disease | degeneration of seminiferous tubules | 4.98e-05 | CGA, FST | 2
Reproductive System Disease | degeneration of Sertoli cells | 0.00293 | HMGB2 | 1
Reproductive System Disease | degeneration of testicular cells | 0.00293 | HMGB2 | 1
Reproductive System Disease | degeneration of germ cells | 0.0203 | HMGB2 | 1
Reproductive System Disease | hyperplasia of Leydig cells | 0.000451 | CGA, FST | 2
Reproductive System Disease | disease process of Leydig cells | 0.0011 | CGA, FST | 2
Reproductive System Disease | disease process of testicular cells | 0.00138 | CGA, FST | 2
Reproductive System Disease | disease process of ovary | 0.0145 | CGA | 1
Reproductive System Disease | disease process of gonad | 0.0374 | CGA | 1
Reproductive System Disease | hemorrhage of ovary | 0.00584 | CGA | 1
Reproductive System Disease | hemorrhage of gonad | 0.00875 | CGA | 1
Reproductive System Disease | infertility | 0.00667 | CGA, FST | 2
Reproductive System Disease | infertility of mice | 0.00667 | CGA, FST | 2
Reproductive System Disease | enlargement of seminal vesicle | 0.00875 | CGA | 1
Reproductive System Disease | enlargement of prostate gland | 0.0117 | CGA | 1
Reproductive System Disease | hematological disorder of ovary | 0.00875 | CGA | 1
Reproductive System Disease | hematological disorder of gonad | 0.0117 | CGA | 1
Reproductive System Disease | invasion of cytotrophoblastic cells | 0.00875 | FST | 1
Reproductive System Disease | adenomyosis | 0.0128 | PHACTR2, TMEFF2 | 2
Reproductive System Disease | endometrial cancer | 0.0137 | CYP1B1, PDGFRB | 2
Reproductive System Disease | endometrial carcinoma | 0.0168 | CYP1B1, PDGFRB | 2
Reproductive System Disease | hypertrophy of Leydig cells | 0.0203 | CGA | 1
Reproductive System Disease | hypertrophy of testicular cells | 0.0232 | CGA | 1
Reproductive System Disease | developmental disorder of Leydig cells | 0.026 | CGA | 1
Reproductive System Disease | developmental disorder of testicular cells | 0.0317 | CGA | 1
Reproductive System Disease | colony formation of ovarian cancer cell lines | 0.0374 | TES | 1
Reproductive System Disease | colony formation of cervical cancer cell lines | 0.0402 | TES | 1
Reproductive System Disease | cell viability of cervical cancer cell lines | 0.0458 | OGG1 | 1
Organ Morphology | thickness of organ | 0.000124 | F2RL1, FST | 2
Organ Morphology | thickness of colon | 0.00293 | F2RL1 | 1
Organ Morphology | size of organ | 0.000798 | CALB1, CGA, FST, KIF5C | 4
Organ Morphology | size of testis | 0.00203 | CGA, FST | 2
Organ Morphology | size of gonad | 0.00322 | CGA, FST | 2
Organ Morphology | size of preantral follicle | 0.00584 | FST | 1
Organ Morphology | size of ear | 0.00875 | FST | 1
Organ Morphology | size of parathyroid gland | 0.00875 | CALB1 | 1
Organ Morphology | size of ovarian follicle | 0.0174 | FST | 1
Organ Morphology | size of ovary | 0.0203 | FST | 1
Organ Morphology | size of brain | 0.0289 | KIF5C | 1
Organ Morphology | atrophy of dermis | 0.00293 | FST | 1
Organ Morphology | atrophy of epidermis | 0.00293 | FST | 1
Organ Morphology | relaxation of bronchus | 0.00584 | F2RL1 | 1
Organ Morphology | relaxation of trachea | 0.00584 | F2RL1 | 1
Organ Morphology | branching of lacrimal gland | 0.00875 | FST | 1
Organ Morphology | branching of exocrine gland | 0.0203 | FST | 1
Organ Morphology | branching of organ | 0.0232 | FST | 1
Organ Morphology | enlargement of prostate gland | 0.0117 | CGA | 1
Organ Morphology | enlargement of organ | 0.0374 | CGA | 1
Organ Morphology | permeability of colon | 0.0117 | F2RL1 | 1
Organ Morphology | permeability of organ | 0.0402 | F2RL1 | 1
Organ Morphology | mass of seminal vesicle | 0.043 | CGA | 1
Organ Morphology | mass of uterus | 0.043 | CGA | 1
Connective Tissue Development and Function | bone mineral density of bone | 0.000142 | CALB1, CGA, TNFRSF11B | 3
Connective Tissue Development and Function | bone mineral density of tibia | 0.00875 | TNFRSF11B | 1
Connective Tissue Development and Function | bone mineral density of lumbar vertebra | 0.0117 | TNFRSF11B | 1
Connective Tissue Development and Function | bone mineral density of trabecular bone | 0.0145 | TNFRSF11B | 1
Connective Tissue Development and Function | bone mineral density of vertebrae | 0.0145 | TNFRSF11B | 1
Connective Tissue Development and Function | bone mineral density of femur | 0.043 | TNFRSF11B | 1
Connective Tissue Development and Function | bone mineral density of limb bone | 0.0458 | TNFRSF11B | 1
Connective Tissue Development and Function | apposition of vertebrae | 0.00293 | TNFRSF11B | 1
Connective Tissue Development and Function | apposition of bone | 0.0232 | TNFRSF11B | 1
Connective Tissue Development and Function | porosity of bone | 0.00293 | TNFRSF11B | 1
Connective Tissue Development and Function | volume of bone | 0.00521 | CGA, TNFRSF11B | 2
Connective Tissue Development and Function | stiffness of lumbar vertebra | 0.00584 | TNFRSF11B | 1
Connective Tissue Development and Function | stiffness of bone | 0.0117 | TNFRSF11B | 1
Connective Tissue Development and Function | mineralization of trabecular bone | 0.00875 | TNFRSF11B | 1
Connective Tissue Development and Function | mineralization of osteoblasts | 0.043 | FST | 1
Connective Tissue Development and Function | morphology of vertebral column | 0.00875 | HAPLN1 | 1
Connective Tissue Development and Function | morphology of skull | 0.0117 | HAPLN1 | 1
Connective Tissue Development and Function | decidualization of stromal cells | 0.0117 | CGA | 1
Connective Tissue Development and Function | formation of colony forming unit osteoblasts | 0.0145 | FST | 1
Connective Tissue Development and Function | formation of granulation tissue | 0.0289 | FST | 1
Connective Tissue Development and Function | formation of osteoclast-like cells | 0.0374 | TNFRSF11B | 1
Connective Tissue Development and Function | quantity of pericytes | 0.0145 | PDGFRB | 1
Connective Tissue Development and Function | mass of trabecular bone | 0.0174 | TNFRSF11B | 1
Connective Tissue Development and Function | activation of hepatic stellate cells | 0.0232 | PDGFRB | 1
Connective Tissue Development and Function | activation of osteoblasts | 0.0289 | TNFRSF11B | 1
Connective Tissue Development and Function | turnover of bone | 0.0232 | TNFRSF11B | 1
Connective Tissue Development and Function | strength of bone | 0.0289 | TNFRSF11B | 1
Connective Tissue Development and Function | proliferation of osteoclasts | 0.0346 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of bone | 0.000142 | CALB1, CGA, TNFRSF11B | 3
Skeletal and Muscular System Development and Function | bone mineral density | 0.000168 | CALB1, CGA, TNFRSF11B | 3
Skeletal and Muscular System Development and Function | bone mineral density of cortical bone | 0.00875 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of tibia | 0.00875 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of lumbar vertebra | 0.0117 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of trabecular bone | 0.0145 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of vertebrae | 0.0145 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of femur | 0.043 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | bone mineral density of limb bone | 0.0458 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | apposition of vertebrae | 0.00293 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | apposition of bone | 0.0232 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | porosity of bone | 0.00293 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | width of medullary cavity | 0.00293 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | width of trabecula | 0.0145 | CGA | 1
Skeletal and Muscular System Development and Function | volume of bone | 0.00521 | CGA, TNFRSF11B | 2
Skeletal and Muscular System Development and Function | formation of osteoid | 0.00584 | CALB1 | 1
Skeletal and Muscular System Development and Function | formation of colony forming unit osteoblasts | 0.0145 | FST | 1
Skeletal and Muscular System Development and Function | formation of osteoclast-like cells | 0.0374 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | length of forelimb | 0.00584 | HAPLN1 | 1
Skeletal and Muscular System Development and Function | length of hindlimb | 0.00584 | HAPLN1 | 1
Skeletal and Muscular System Development and Function | length of limb | 0.0232 | HAPLN1 | 1
Skeletal and Muscular System Development and Function | stiffness of lumbar vertebra | 0.00584 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | stiffness of bone | 0.0117 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | mineralization of trabecular bone | 0.00875 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | mineralization of osteoblasts | 0.043 | FST | 1
Skeletal and Muscular System Development and Function | morphology of growth plate | 0.00875 | CALB1 | 1
Skeletal and Muscular System Development and Function | morphology of vertebral column | 0.00875 | HAPLN1 | 1
Skeletal and Muscular System Development and Function | morphology of skull | 0.0117 | HAPLN1 | 1
Skeletal and Muscular System Development and Function | morphology of skeleton | 0.026 | CALB1 | 1
Skeletal and Muscular System Development and Function | osteoclastogenesis of leukocyte cell lines | 0.00875 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | osteoclastogenesis of peripheral blood monocytes | 0.00875 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | osteoclastogenesis of bone cell lines | 0.0117 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | osteoclastogenesis of monocytes | 0.0203 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | osteoclastogenesis of cell lines | 0.0374 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | skeletal and muscular process of leukocyte cell lines | 0.0145 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | skeletal and muscular process of bone cell lines | 0.0174 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | mass of trabecular bone | 0.0174 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | mass of skeletal muscle | 0.0374 | FST | 1
Skeletal and Muscular System Development and Function | quantity of trabecula | 0.0203 | CGA | 1
Skeletal and Muscular System Development and Function | turnover of bone | 0.0232 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | activation of osteoblasts | 0.0289 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | myogenesis of muscle | 0.0289 | PDGFRB | 1
Skeletal and Muscular System Development and Function | strength of bone | 0.0289 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | development of bone cell lines | 0.0317 | TNFRSF11B | 1
Skeletal and Muscular System Development and Function | proliferation of osteoclasts | 0.0346 | TNFRSF11B | 1
Cardiovascular System Development and Function | quantity of capillary vessel | 0.000173 | F2RL1, PDGFRB | 2
Cardiovascular System Development and Function | quantity of glomerular capillary | 0.00293 | PDGFRB | 1
Cardiovascular System Development and Function | quantity of blood vessel | 0.00367 | F2RL1, PDGFRB | 2
Cardiovascular System Development and Function | blood pressure of left ventricle | 0.00293 | CRYAB | 1
Cardiovascular System Development and Function | proliferation of tunica intima | 0.00293 | TNFRSF11B | 1
Cardiovascular System Development and Function | proliferation of tunica media | 0.00293 | TNFRSF11B | 1
Cardiovascular System Development and Function | relaxation of femoral artery | 0.00584 | F2RL1 | 1
Cardiovascular System Development and Function | remodeling of vascular tissue | 0.0203 | PDGFRB | 1
Tissue Morphology | quantity of capillary vessel | 0.000173 | F2RL1, PDGFRB | 2
Tissue Morphology | quantity of glomerular capillary | 0.00293 | PDGFRB | 1
Tissue Morphology | quantity of blood vessel | 0.00367 | F2RL1, PDGFRB | 2
Tissue Morphology | quantity of mesangial cells | 0.0117 | PDGFRB | 1
Tissue Morphology | quantity of endocrine cells | 0.0141 | CGA, FST | 2
Tissue Morphology | quantity of pericytes | 0.0145 | PDGFRB | 1
Tissue Morphology | quantity of somatotrophs | 0.0203 | CGA | 1
Tissue Morphology | quantity of trabecula | 0.0203 | CGA | 1
Tissue Morphology | quantity of lactotropes | 0.0232 | CGA | 1
Tissue Morphology | quantity of neuronal progenitor cells | 0.0232 | FST | 1
Tissue Morphology | quantity of exocrine cells | 0.0346 | FST | 1
Tissue Morphology | quantity of liver cells | 0.043 | PDGFRB | 1
Tissue Morphology | quantity of multilineage progenitor cells | 0.043 | OGG1 | 1
Tissue Morphology | area of scar tissue | 0.00293 | FST | 1
Tissue Morphology | collapse of epiphysis | 0.00293 | TNFRSF11B | 1
Tissue Morphology | destruction of cortical bone | 0.00293 | TNFRSF11B | 1
Tissue Morphology | destruction of growth plate | 0.00293 | TNFRSF11B | 1
Tissue Morphology | destruction of trabecula | 0.00293 | TNFRSF11B | 1
Tissue Morphology | destruction of bone | 0.0402 | TNFRSF11B | 1
Tissue Morphology | destruction of cartilage tissue | 0.0402 | TNFRSF11B | 1
Tissue Morphology | hypertrophy of extensor digitorum longus muscle | 0.00293 | FST | 1
Tissue Morphology | hypertrophy of quadriceps femoris | 0.00293 | FST | 1
Tissue Morphology | hypertrophy of anterior tibial muscle | 0.00584 | FST | 1
Tissue Morphology | hypertrophy of hindlimb muscle | 0.00584 | FST | 1
Tissue Morphology | hypertrophy of skeletal muscle | 0.0117 | FST | 1
Tissue Morphology | loss of cortical bone | 0.00293 | TNFRSF11B | 1
Tissue Morphology | loss of cartilage tissue | 0.00584 | TNFRSF11B | 1
Tissue Morphology | loss of trabecular bone | 0.0174 | TNFRSF11B | 1
Tissue Morphology | relaxation of bronchial tissue | 0.00293 | F2RL1 | 1
Tissue Morphology | relaxation of femoral artery | 0.00584 | F2RL1 | 1
Tissue Morphology | strength of wound | 0.00293 | FST | 1
Tissue Morphology | strength of bone | 0.0289 | TNFRSF11B | 1
Tissue Morphology | width of medullary cavity | 0.00293 | TNFRSF11B | 1
Tissue Morphology | width of trabecula | 0.0145 | CGA | 1
Tissue Morphology | volume of bone | 0.00521 | CGA, TNFRSF11B | 2
Tissue Morphology | volume of tissue | 0.0073 | CGA, TNFRSF11B | 2
Tissue Morphology | arrest in erosion of bone | 0.00584 | TNFRSF11B | 1
Tissue Morphology | erosion of bone | 0.043 | TNFRSF11B | 1
Tissue Morphology | morphology of growth plate | 0.00875 | CALB1 | 1
Tissue Morphology | morphology of vertebral column | 0.00875 | HAPLN1 | 1
Tissue Morphology | morphology of skull | 0.0117 | HAPLN1 | 1
Tissue Morphology | mass of trabecular bone | 0.0174 | TNFRSF11B | 1
Tissue Morphology | mass of skeletal muscle | 0.0374 | FST | 1
Tissue Morphology | remodeling of vascular tissue | 0.0203 | PDGFRB | 1
Tissue Morphology | remodeling of tissue | 0.039 | PDGFRB, TNFRSF11B | 2
Tissue Morphology | repair of wound | 0.0203 | FST | 1
Tissue Morphology | modification of wound | 0.0232 | FST | 1
Organismal Development | length of body region | 0.00037 | FST, HAPLN1 | 2
Organismal Development | length of forelimb | 0.00584 | HAPLN1 | 1
Organismal Development | length of hindlimb | 0.00584 | HAPLN1 | 1
Organismal Development | length of tail | 0.00875 | FST | 1
Organismal Development | length of limb | 0.0232 | HAPLN1 | 1
Organismal Development | quantity of vessel | 0.00441 | F2RL1, PDGFRB | 2
Organismal Development | mass of body | 0.00584 | FST | 1
Cancer | hyperplasia of Leydig cells | 0.000451 | CGA, FST | 2
Cancer | hyperplasia of gonadal cells | 0.00054 | CGA, FST | 2
Cancer | hyperplasia of anterior tibial muscle | 0.00293 | FST | 1
Cancer | hyperplasia of extensor digitorum longus muscle | 0.00293 | FST | 1
Cancer | hyperplasia of quadriceps femoris | 0.00293 | FST | 1
Cancer | hyperplasia of thyrotropes | 0.00875 | CGA | 1
Cancer | hyperplasia of pituitary cells | 0.0145 | CGA | 1
Cancer | hyperplasia of muscle | 0.0232 | FST | 1
Cancer | hyperplasia of eukaryotic cells | 0.0267 | CGA, FST | 2
Cancer | hyperplasia of cells | 0.0296 | CGA, FST | 2
Cancer | pathological cyst | 0.00636 | CALB1, CGA | 2
Cancer | invasion of cytotrophoblastic cells | 0.00875 | FST | 1
Cancer | invasion of trophoblast cells | 0.0174 | FST | 1
Cancer | invasion of embryonic cells | 0.0203 | FST | 1
Cancer | onset of formation of tumor | 0.0117 | OGG1 | 1
Cancer | formation of ovarian cyst | 0.0145 | CGA | 1
Cancer | formation of tumor | 0.0174 | CGA, OGG1, PDGFRB | 3
Cancer | formation of T-cell non-hodgkin lymphoma | 0.026 | PDGFRB | 1
Cancer | formation of B-cell non-hodgkin lymphoma | 0.0317 | PDGFRB | 1
Cancer | formation of sarcoma | 0.0402 | OGG1 | 1
Cancer | formation of squamous-cell carcinoma | 0.043 | OGG1 | 1
Cancer | endometrial cancer | 0.0137 | CYP1B1, PDGFRB | 2
Cancer | endometrial carcinoma | 0.0168 | CYP1B1, PDGFRB | 2
Cancer | dermatofibrosarcoma | 0.0174 | PDGFRB | 1
Cancer | hyperproliferation of brain cells | 0.0174 | CGA | 1
Cancer | differentiation of rhabdomyosarcoma cell lines | 0.0203 | FST | 1
Cancer | chondrosarcoma | 0.0232 | PDGFRB | 1
Cancer | capillary hemangioma | 0.026 | PDGFRB | 1
Cancer | growth of stomach cancer cell lines | 0.026 | F2RL1 | 1
Cancer | myelofibrosis | 0.026 | PDGFRB | 1
Cancer | ovarian cyst | 0.026 | CGA | 1
Cancer | colorectal adenocarcinoma | 0.0289 | TMEFF2 | 1
Cancer | renal cyst | 0.0289 | CALB1 | 1
Cancer | neoplasia of mice | 0.0314 | PDGFRB, TES | 2
Cancer | neoplasia of rodents | 0.0326 | PDGFRB, TES | 2
Cancer | [NAME] of mammalia | 0.0424 | PDGFRB, TES | 2
Cancer | neuritogenesis of pheochromocytoma cell lines | 0.0317 | PDGFRB | 1
Cancer | tumorigenesis of mice | 0.0326 | PDGFRB, TES | 2
Cancer | tumorigenesis of rodents | 0.0345 | PDGFRB, TES | 2
Cancer | tumorigenesis of mammalia | 0.0444 | PDGFRB, TES | 2
Cancer | adrenal cortex carcinoma | 0.0346 | PDGFRB | 1
Cancer | meningioma | 0.0346 | PDGFRB | 1
Cancer | [NAME] syndrome | 0.0346 | PDGFRB | 1
Cancer | bladder cancer | 0.0364 | PDGFRB, PSIP1 | 2
Cancer | cell viability of colorectal cancer cell lines | 0.0374 | OGG1 | 1
Cancer | cell viability of cervical cancer cell lines | 0.0458 | OGG1 | 1
Cancer | colony formation of ovarian cancer cell lines | 0.0374 | TES | 1
Cancer | colony formation of cervical cancer cell lines | 0.0402 | TES | 1
Cancer | developmental process of rhabdomyosarcoma cell lines | 0.0374 | FST | 1
Cancer | transformation of bone marrow cells | 0.0374 | PDGFRB | 1
Cancer | adrenal cortex tumor | 0.0402 | PDGFRB | 1
Cancer | renal-cell carcinoma | 0.041 | OGG1, PDGFRB | 2
Cancer | adrenal gland tumor | 0.043 | PDGFRB | 1
Cancer | colorectal cancer | 0.0442 | CYP1B1, FST, HMGB2, PDGFRB, TNFRSF11B | 5